Amgen stock reversed higher Wednesday after the biotech behemoth said the Food and Drug Administration placed one of its obesity treatments on clinical hold. This means Amgen can't run testing of ...

Lawmakers and the microchip industry are struggling to respond to President Donald Trump’s sudden demand that Congress “get rid of” the landmark CHIPS and Science Act, a popular $52.7 ...